Novel pentafluorosulfanyl-containing triclocarban analogs selectively kill Gram-positive bacteria
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.00071-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Ali Pormohammad und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Faculty of Science, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Carbanilides, Anti-Bacterial Agents, Gram-Positive Bacteria, Microbial Sensitivity Tests. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC), EC | European Regional Development Fund (ERDF).
Abstract (Originalsprache)
Novel antimicrobial agents are needed to combat antimicrobial resistance. This study tested novel pentafluorosulfanyl-containing triclocarban analogs for their potential antibacterial efficacy. Standard procedures were used to produce pentafluorosulfanyl-containing triclocarban analogs. Twenty new compounds were tested against seven Gram-positive and Gram-negative indicator strains as well as 10 clinical isolates for their antibacterial and antibiofilm activity. Mechanistic investigations focused on damage to cell membrane, oxidizing reduced thiols, iron-sulfur clusters, and oxidative stress to explain the compounds’ activity. Safety profiles were assessed using cytotoxicity experiments in eukaryotic cell lines. Following screening, selected components had significantly better antibacterial and antibiofilm activity against Gram-positive bacteria in lower concentrations in comparison to ciprofloxacin and gentamycin. For instance, one compound had a minimum inhibitory concentration of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Faculty of Science, University of Calgary, Calgary, Alberta, Canada.
- MHCombiotic Inc., Calgary, Alberta, Canada.
- Department of Microbiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran.
- Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
- Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Barcelona, Spain.
- Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Barcelona, Spain.
ORCID-Profile: Ali Pormohammad, Melika Moradi, Lieve Naesens, Santiago Vázquez, Raymond J Turner
Förderung
- Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC)
- EC | European Regional Development Fund (ERDF)
Zitieren
APA
Pormohammad, A., Moradi, M., Hommes, J. W., Pujol, E., Naesens, L., Vázquez, S., Surewaard, B. G. J., Zarei, M., Vazquez-Carrera, M., & Turner, R. J. (2024). Novel pentafluorosulfanyl-containing triclocarban analogs selectively kill Gram-positive bacteria. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00071-24
Vancouver
Pormohammad A, Moradi M, Hommes JW, Pujol E, Naesens L, Vázquez S, et al. Novel pentafluorosulfanyl-containing triclocarban analogs selectively kill Gram-positive bacteria. Microbiology Spectrum. 2024. doi:10.1128/spectrum.00071-24
BibTeX
@article{Pormohammad2024,
author = {Pormohammad, Ali and Moradi, Melika and Hommes, Josefien W and Pujol, Eugènia and Naesens, Lieve and Vázquez, Santiago and Surewaard, Bas G J and Zarei, Mohammad and Vazquez-Carrera, Manuel and Turner, Raymond J},
title = {Novel pentafluorosulfanyl-containing triclocarban analogs selectively kill Gram-positive bacteria},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.00071-24}
}
EUVIMED